Home › Funds › TYNDALL CAPITAL PARTNERS L P › CYCN

TYNDALL CAPITAL PARTNERS L P position in CYCN

CYCLERION THERAPEUTICS INC

TYNDALL CAPITAL PARTNERS L P reported holding 155,187 shares of CYCN (CYCLERION THERAPEUTICS INC) in its Q2 2025 13F filing — a position valued at US$452K, representing 100.00% of its reported portfolio and ranking #1 among its reported holdings. TYNDALL CAPITAL PARTNERS L P has disclosed CYCN holdings in 8 of the last 8 reported quarters, going back to Q3 2023.

Latest position (Q2 2025)155.19K sh
Reported value held$451.59K
Portfolio Weight100.00%
First reportedQ3 2023
Last changeReduce
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How TYNDALL CAPITAL PARTNERS L P's CYCN position evolved

TYNDALL CAPITAL PARTNERS L P first disclosed a stake in CYCN in Q3 2023 at 147,712 shares (US$505K). The position peaked in Q4 2023 at 164,429 shares, worth US$551K. Across 8 filings, TYNDALL CAPITAL PARTNERS L P increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2025) shows 155,187 shares valued at US$452K — a reduction of -9,590 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 147.71K $505.18K New
Q4 2023 164.43K $550.84K Add
Q1 2024 164.78K $527.29K Hold
Q2 2024 164.78K $378.99K Hold
Q3 2024 164.78K $426.77K Hold
Q4 2024 164.78K $530.58K Hold
Q1 2025 164.78K $411.94K Hold
Q2 2025 155.19K $451.59K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CYCN and 13F data

CYCN (CYCLERION THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 23 other funds we track also report a position in CYCN — the largest reported positions include Kalehua Capital Management LLC (US$5.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CYCN

All CYCN fund holders →

FAQ

How long has TYNDALL CAPITAL PARTNERS L P held CYCN?

TYNDALL CAPITAL PARTNERS L P has disclosed CYCN holdings in 8 of the last 8 reported quarters, going back to Q3 2023.

What is TYNDALL CAPITAL PARTNERS L P's current position in CYCN?

As of Q2 2025, TYNDALL CAPITAL PARTNERS L P holds 155.19K shares of CYCN (CYCLERION THERAPEUTICS INC), valued at $451.59K, representing 100.00% of its reported portfolio and ranking #1.

Has TYNDALL CAPITAL PARTNERS L P been buying or selling CYCN?

In the latest 13F filing (Q2 2025), TYNDALL CAPITAL PARTNERS L P reduced its position in CYCN. The position peaked in Q4 2023 at 164.43K shares.

Which other funds hold CYCN?

Other major institutional holders of CYCN include Kalehua Capital Management LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.